Endpoints News 2026-02-09 #ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%
Endpoints News 2026-02-09 Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages
Endpoints News 2026-02-07 #ACTRIMS26: Sanofi unpacks data from a failed Phase 3 tolebrutinib trial in PPMS
Endpoints News 2026-02-07 The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more